SCHEMBL3393411

SCHEMBL3393411

CC(=O)[C@@]1(O)CC[C@H]2[C@@H]3C[C@H](C)C4=CC(=O)CC[C@]4(C)C3=CC[C@@]21C

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR3C1 P04150 6/20 0.58
LMNA P02545 6/20 0.58
HIF1A Q16665 5/20 0.58
MEN1 O00255 3/20 0.58
KMT2A Q03164 3/20 0.58
MAPT P10636 2/20 0.58
CYP2C19 P33261 2/20 0.58
CYP3A4 P08684 5/20 0.53
ALDH1A1 P00352 2/20 0.53
CYP2C9 P11712 2/20 0.53
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SERPINA6 P08185 2/20 0.45
SHBG P04278 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.45
ADORA3 P0DMS8 1/20 0.45
MAPK3 P27361 1/20 0.45
BLM P54132 1/20 0.45
SLC6A3 Q01959 1/20 0.45
PGR P06401 4/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13069733 1.00 NR3C1 (0.58) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL8201277 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL12265810 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL11702398 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL8201270 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL11702404 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL15144390 0.89 NR3C1 (0.57) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL10412565 0.88 NR3C1 (0.56) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL15147191 0.87 NR3C1 (0.62) NR3C1LMNAHIF1AMEN1KMT2A
SCHEMBL11703940 0.87 NR3C1 (0.50) NR3C1LMNAHIF1AMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2246359-A1 Process for obtaining fluorometholone and intermediates therefor Crystal Pharma, S.L.U. (ES) 2010-11-03 EP disclosed
EP-0187847-A1 PROCESS FOR THE MANUFACTURE OF 6$g(A)-METHYL STEROIDS SCHERING AKTIENGESELLSCHAFT (DE) 1986-07-23 EP disclosed
WO-1986000907-A1 PROCESS FOR THE MANUFACTURE OF 6ALPHA-METHYL STEROIDS SCHERING AKTIENGESELLSCHAFT BERLIN UND BERGKAMEN (DE) 1986-02-13 WO disclosed